Hypersensitivity reactions from antineoplastic agents

[1]  J. Burchenal,et al.  Phase-II trial of 1,2-diaminocyclohexane (4-carboxyphthalato) platinum (II) (DACCP) in non-small cell lung cancer , 1984, Cancer Chemotherapy and Pharmacology.

[2]  H. Eyre,et al.  Randomized comparisons of radiotherapy and CCNU versus radiotherapy, CCNU plus procarbazine for the treatment of malignant gliomas following surgery , 2004, Journal of Neuro-Oncology.

[3]  G. Curt,et al.  Skin reactions induced by trimetrexate, an analog of methotrexate , 2004, Investigational New Drugs.

[4]  Mark R. Green,et al.  Pharmacokinetics and toxicity of 5-day continuous infusion of vinblastine , 2004, Cancer Chemotherapy and Pharmacology.

[5]  G. Hortobagyi,et al.  Phase II study of VP16-213 (Etoposide) in refractory metastatic breast carcinoma , 2004, Cancer Chemotherapy and Pharmacology.

[6]  J. M. Gracia,et al.  Chemotherapy combination with cyclophosphamide (CTX) adriamycin (ADM), vincristine (VCR), and VP16-213 in small cell carcinoma of the lung (SCCL) , 2004, Cancer Chemotherapy and Pharmacology.

[7]  I. Smith,et al.  Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II , 2004, Cancer Chemotherapy and Pharmacology.

[8]  Noel R. Rose,et al.  Manual of clinical laboratory immunology , 2002 .

[9]  N. Mendell,et al.  Preventive allergy: genetics of IgE-mediated diseases. , 1986, The Journal of allergy and clinical immunology.

[10]  L. Lichtenstein,et al.  Abnormalities of basophil "releasability" in atopic and asthmatic individuals. , 1986, The Journal of allergy and clinical immunology.

[11]  R. Gelber,et al.  Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia. , 1986, The New England journal of medicine.

[12]  E. Gehan,et al.  Randomized comparisons of radiotherapy and carmustine versus procarbazine versus dacarbazine for the treatment of malignant gliomas following surgery: a Southwest Oncology Group Study. , 1986, Cancer treatment reports.

[13]  J. Wilson,et al.  Parenteral Benzyl Alcohol-Induced Hypersensitivity Reaction , 1986, Drug intelligence & clinical pharmacy.

[14]  R. Kyle,et al.  Single, sequential, and multiple alkylating agent therapy for multiple myeloma: a CALGB Study. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  K. Sridhar.  Allergic reaction to 5‐fluorouracil infusion , 1986, Cancer.

[16]  B. Leyland-Jones,et al.  Hypersensitivity reactions to teniposide (VM-26): an analysis. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  J. Allen,et al.  Phase I study of carboplatin (CBDCA) in children with cancer. , 1986, Cancer treatment reports.

[18]  K. Beutner,et al.  Neutrophilic eccrine hidradenitis associated with Hodgkin's disease and chemotherapy. A case report. , 1986, Archives of dermatology.

[19]  B. Cantwell,et al.  ALLERGIC REACTIONS TO MITOXANTRONE , 1986, The Lancet.

[20]  M. Kris,et al.  Phase I trial of taxol given as a 3-hour infusion every 21 days. , 1986, Cancer treatment reports.

[21]  R. Fellous,et al.  Human antibodies to the antineoplastic drug elliptinium: characterization and structure-activity relationships. , 1986, The Journal of allergy and clinical immunology.

[22]  G. Frentz,et al.  [Mitomycin C-induced palmar exanthema]. , 1986, Ugeskrift for læger.

[23]  A. Millá Santos,et al.  Anaphylactic reaction following i.v. administration of 5-fluorouracil. , 1986, Cancer treatment reports.

[24]  J. Ajani,et al.  Fluorouracil-associated dermatitis of the hands and feet. , 1985, JAMA.

[25]  L. Pirtoli,et al.  Etoposide-induced hypersensitivity reactions. Report of two cases. , 1985, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy.

[26]  R. Willemze,et al.  Palmar-plantar skin changes and cytarabine. , 1985, Annals of internal medicine.

[27]  P. Saidi,et al.  Hypersensitivity reaction to a metabolite of cyclophosphamide. , 1985, The Journal of allergy and clinical immunology.

[28]  M. Goos,et al.  HYPERSENSITIVITY TO MESNA , 1985, The Lancet.

[29]  A. Manoharan.  The cytarabine syndrome in adults. , 1985, Australian and New Zealand journal of medicine.

[30]  Weiss Rb,et al.  Hemolytic anemia associated with antineoplastic agents. , 1985 .

[31]  C. Théodore,et al.  Phase II trial of elliptinium in advanced renal cell carcinoma. , 1985, Cancer treatment reports.

[32]  J. Marks.  Opium, the religion of the people. , 1985, Lancet.

[33]  B. Griffith,et al.  Anaphylactoid Reactions Associated with Parenteral Cyclosporine Use: Possible Role of Cremophor EL , 1985, Drug intelligence & clinical pharmacy.

[34]  S. Ackland,et al.  Immediate hypersensitivity to mannitol: a potential cause of apparent hypersensitivity to cisplatin. , 1985, Cancer treatment reports.

[35]  J. Bidart,et al.  Drug-induced antibodies during 2-N-methyl-9-hydroxyellipticinium acetate (NSC-264137) treatment: schedule dependency and relationship to hemolysis. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  L. King,et al.  Palmar-plantar erythrodysesthesia and cytarabine. , 1985, Annals of internal medicine.

[37]  A. Howell,et al.  Activity of JM9 in advanced ovarian cancer: a phase I-II trial. , 1985, Cancer treatment reports.

[38]  R. Wittes,et al.  Phase I and clinical pharmacological evaluation of 4'-deoxydoxorubicin in patients with advanced cancer. , 1985, Cancer research.

[39]  V. Wahn,et al.  Anaphylaxis to L-asparaginase during treatment for acute lymphoblastic leukemia in children--evidence of a complement-mediated mechanism. , 1985, Pediatric research.

[40]  J. Atkins.  Fluorouracil and the palmar-plantar erythrodysesthesia syndrome. , 1985, Annals of internal medicine.

[41]  Weiss Rb,et al.  Hypersensitivity reactions to amsacrine. , 1985 .

[42]  J. Routy,et al.  [Fatal complication during treatment with elliptinium acetate]. , 1985, Presse medicale.

[43]  I. Royer,et al.  Décès au cours d'un traitement par ellipticine. , 1985 .

[44]  J. Routy,et al.  Accident mortel au cours d'un traitement par l'acétate d'elliptinium , 1985 .

[45]  A. Lorincz,et al.  Distinctive acral erythema occurring during therapy for severe myelogenous leukemia. , 1985, Archives of dermatology.

[46]  A. Green,et al.  Allergic reactions to teniposide in patients with neuroblastoma and lymphoid malignancies. , 1985, Cancer treatment reports.

[47]  J. Lokich,et al.  Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome. , 1984, Annals of internal medicine.

[48]  M. Markman.  NO INCREASE IN ALLERGIC REACTIONS WITH INTRACAVITARY ADMINISTRATION OF CISPLATIN , 1984, The Lancet.

[49]  M. Tavassoli,et al.  Fulminant and fatal angioedema caused by bleomycin treatment. , 1984, Archives of internal medicine.

[50]  E. Pomfret,et al.  Phase II trial of etoposide in previously treated small cell carcinoma of the lung. , 1984, Cancer treatment reports.

[51]  J. Wilson,et al.  Doxorubicin-Induced Hypersensitivity Reactions , 1984, Drug intelligence & clinical pharmacy.

[52]  P. O'dwyer,et al.  Anaphylactic reactions to diaziquone. , 1984, Cancer treatment reports.

[53]  G. Murphy,et al.  Neutrophilic eccrine hidradenitis: a distinctive rash associated with cytarabine therapy and acute leukemia. , 1984, Journal of the American Academy of Dermatology.

[54]  Weiss Rb,et al.  Hypersensitivity reactions induced by etoposide. , 1984 .

[55]  R. Willkens,et al.  Small-vessel vasculitis and methotrexate. , 1984, Annals of internal medicine.

[56]  S. Deodhar,et al.  Interpretation of Immunofluorescent Patterns in Skin Diseases , 1984 .

[57]  H. Spencer.  Local erythema multiforme‐like drug reaction following intravenous mitomycin C and 5‐fluorouracil , 1984 .

[58]  L. Lewis.  Procarbazine associated alveolitis. , 1984, Thorax.

[59]  F. Cavalli,et al.  Phase II study of 9-hydroxy-2N-methylellipticinium acetate. , 1984, European Journal of Cancer and Clinical Oncology.

[60]  T. Kasamatsu,et al.  [Allergic reaction to CDDP: report of 4 cases]. , 1984, Hinyokika kiyo. Acta urologica Japonica.

[61]  K. Havemann,et al.  Acute Allergic Reaction Due to Vincristine Sulfate , 1984 .

[62]  S. Howell,et al.  Anaphylactic reaction to cytarabine: in vitro evidence that the response is immunoglobulin E mediated. , 1984, Medical and pediatric oncology.

[63]  P. O'dwyer,et al.  Hypersensitivity reactions induced by etoposide. , 1984, Cancer treatment reports.

[64]  L. Pendyala,et al.  Phase I clinical trial of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum(IV) (CHIP). , 1983, Cancer treatment reports.

[65]  P. Woolley,et al.  Methotrexate‐induced immune haemolytic anaemia , 1983, British journal of haematology.

[66]  H. Lazarus,et al.  High-dose cytosine arabinoside therapy for refractory leukemia. , 1983, Blood.

[67]  C. Schmidt,et al.  Anaphylaktische Reaktion unter Cyclophosphamid-Infusion , 1983 .

[68]  L. Denis.  ANAPHYLACTIC REACTIONS TO REPEATED INTRAVESICAL INSTILLATION WITH CISPLATIN , 1983, The Lancet.

[69]  B. Chabner,et al.  Erythema and desquamation after high-dose methotrexate. , 1983, Annals of internal medicine.

[70]  Shah Ss,et al.  The cytarabine syndrome in an adult. , 1983 .

[71]  L. Petz.  Autoimmune hemolytic anemia. , 1983, Human pathology.

[72]  M. Bern,et al.  Bleomycin-induced fatal hyperpyrexia. , 1983, The American journal of medicine.

[73]  D. Heuer,et al.  Ocular toxicity from high‐dose cytosine arabinoside , 1983, Cancer.

[74]  M. Rybak,et al.  The cytarabine syndrome in an adult. , 1983, Cancer treatment reports.

[75]  G. Koehn,et al.  Unusual local cutaneous reaction to dacarbazine. , 1982, Archives of dermatology.

[76]  G. Cohen,et al.  Phase II trial of mitoxantrone. , 1982, Cancer treatment reports.

[77]  J. Burchenal,et al.  Phase I clinical trial and pharmacokinetics of 4'-carboxyphthalato(1,2-diaminocyclohexane)platinum(II). , 1982, Cancer research.

[78]  J. Roujeau,et al.  Cancer chemotherapy and acral erythema. , 1982, Annals of internal medicine.

[79]  W. Whitmore,et al.  Intravesical cisplatin for superficial bladder tumors , 1982, Cancer.

[80]  F. Bleichner,et al.  Jak klikatá je cesta onkologického pacienta k onkologovi , 1982 .

[81]  W. Burgdorf,et al.  Peculiar acral erythema secondary to high-dose chemotherapy for acute myelogenous leukemia. , 1982, Annals of internal medicine.

[82]  A. Baumelou,et al.  Immune hemolytic anemia and renal failure due to teniposide. , 1982, The New England journal of medicine.

[83]  R. Weiss,et al.  Hypersensitivity reactions to cancer chemotherapeutic agents. , 1982, Annals of internal medicine.

[84]  M. Mihm,et al.  Neutrophilic Eccrine Hidradenitis: A Distinctive Type of Neutrophilic Dermatosis Associated With Myelogenous Leukemia and Chemotherapy , 1982 .

[85]  R. Weiss.  Hypersensitivity reaction to cancer chemotherapy. , 1982, Seminars in oncology.

[86]  F. Cabanillas,et al.  Studies with ifosfamide in patients with malignant lymphoma. , 1982, Seminars in oncology.

[87]  M. Soloway,et al.  Side Effects Associated with Intravesical Mitomycin C , 1981 .

[88]  R. Diasio,et al.  cis-Platinum in gynecologic cancer , 1981 .

[89]  R. Diasio,et al.  cis-Platinum in gynecologic cancer. III. Toxicity. , 1981, American journal of obstetrics and gynecology.

[90]  P. Vanarsdel.  Drug allergy, an update. , 1981, The Medical clinics of North America.

[91]  A. Baumelou,et al.  ACUTE INTRAVASCULAR HAEMOLYSIS AND RENAL FAILURE DUE TO TENIPOSIDE RELATED ANTIBODY , 1981, The Lancet.

[92]  H. Hansen,et al.  Vindesine in the treatment of small cell anaplastic bronchogenic carcinoma. , 1981, Cancer treatment reports.

[93]  W. Crist,et al.  The cytosine arabinoside (Ara-C) syndrome. , 1981, Medical and pediatric oncology.

[94]  R. Verwilghen,et al.  Drug Dependent Red Cell Antibodies and Intravascular Haemolysis Occurring in Patients Treated with 9 Hydroxy‐Methyl‐Ellipticinium , 1980, British journal of haematology.

[95]  P. L. Smith,et al.  Physiologic manifestations of human anaphylaxis. , 1980, The Journal of clinical investigation.

[96]  W. Isacoff,et al.  Protein‐methotrexate‐IgG complexes in the serum of patients receiving high‐dose antifolate therapy , 1980, Cancer.

[97]  J. Watkins,et al.  Suspected anaphylactic reaction to Cremophor EL. , 1980, British medical journal.

[98]  C. Tropé,et al.  Bleomycin alone or combined with mitomycin C in treatment of advanced or recurrent squamous cell carcinoma of the vulva. , 1980, Cancer treatment reports.

[99]  E. Crum,et al.  Cytarabine-induced anaphylaxis. Demonstration of antibody and successful desensitization. , 1980, Archives of internal medicine.

[100]  B. Kabakow,et al.  Anaphylactoid reaction. Associated with intravenous administration of 5-fluorouracil. , 1979, New York state journal of medicine.

[101]  J. Keogh,et al.  Anaphylactoid reaction to mannitol , 1979, Canadian Anaesthetists' Society journal.

[102]  M. Or,et al.  Hypersensitivity reactions to iv melphalan during treatment of multiple myeloma: Cancer and Leukemia Group B experience. , 1979 .

[103]  M. Corder,et al.  Successful re-treatment with cis-dichlorodiammineplatinum(II) after apparent allergic reactions. , 1979, Cancer treatment reports.

[104]  Kligman Am,et al.  Reactions" to standard patch test materials. , 1979 .

[105]  M. Nesbit,et al.  Evaluation of intramuscular versus intravenous administration of L-asparaginase in childhood leukemia. , 1979, The American journal of pediatric hematology/oncology.

[106]  J. Leyden,et al.  "Reactions" to standard patch test materials. , 1979, Acta dermato-venereologica. Supplementum.

[107]  C. D'Orsi,et al.  Pulmonary reaction associated with neocarzinostatin therapy. , 1978, Cancer treatment reports.

[108]  M. Ecker,et al.  Procarbazine lung. , 1978, AJR. American journal of roentgenology.

[109]  R. Cahill,et al.  Generalized urticaria to cyclophosphamide: Type I hypersensitivity to an immunosuppressive agent. , 1976, The Journal of allergy and clinical immunology.

[110]  J. Pepys,et al.  Immediate (type I) allergic responses to platinum compounds , 1976, Clinical allergy.

[111]  G. Opelz,et al.  Hypersensitivity to procarbazine associated with angioedema, urticaria, and low serum complement activity. , 1976, The Journal of allergy and clinical immunology.

[112]  N. Hill,et al.  Atopic hypersensitivity to cis-dichlorodiammineplatinum(II) and other platinum complexes. , 1975, Cancer research.

[113]  W. Hengstebeck,et al.  FASTING SERUM-GASTRIN IN CHRONIC GASTRITIS , 1975, The Lancet.

[114]  P. Hochstein,et al.  POTENTIAL VARIANTS OF PHENYLKETONURIA , 1975, The Lancet.

[115]  E. V. Van Scott,et al.  Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance , 1973, Cancer.

[116]  J. Lokich,et al.  Allergic reaction to procarbazine , 1972, Clinical pharmacology and therapy.

[117]  R. Castellino,et al.  Hypersensitivity to procarbazine (Matulane®) manifested by fever and pleuropulmonary reaction , 1972, Cancer.

[118]  J. David,et al.  Detection in vitro of cellular hypersensitivity to drugs. , 1971, The Journal of allergy and clinical immunology.

[119]  J. Hill,et al.  Atopic Hypersensitivity to L-Asparaginase , 1971 .

[120]  K. Brunner,et al.  A METHYLHYDRAZINE DERIVATIVE IN HODGKIN'S DISEASE AND OTHER MALIGNANT NEOPLASMS. THERAPEUTIC AND TOXIC EFFECTS STUDIED IN 51 PATIENTS. , 1965, Annals of internal medicine.

[121]  R. Maclennan.  MORE ABOUT METHYSERGIDE. , 1964, Lancet.

[122]  D. Hunter,et al.  Asthma Caused by the Complex Salts of Platinum , 1945 .